SPARC regulates cell cycle progression in mesangial cells via its inhibition of IGF-dependent signaling

Journal of Cellular Biochemistry

Volumn 88, Issue 4, 2003, Pages 802-811

  Francki, Aleksandar ^a,b   Motamed, Kouros ^a,c   McClure, Timothy D ^a   Kaya, Marcus ^a   Murri, Carrie ^a   Blake, David J ^a   Carbon, Juliet G ^a   Sage, E Helene ^a  

^a HOPE HEART INSTITUTE   (United States)

^b AmCyte Inc   (United States)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Cell cycle; Cyclin D1; IGF system; Matricellular; Mesangial cells; p21; p27; Proliferation; SPARC

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR; CYSTEINE; GROWTH FACTOR; MATRIX PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; OSTEONECTIN; PROTEIN P21; PROTEIN P27; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL INTERACTION; CELL PROLIFERATION; CELL REGENERATION; CELL TYPE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DNA SYNTHESIS; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; GLOMERULUS; KIDNEY HYPERTROPHY; KIDNEY INJURY; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MESANGIUM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN SYNTHESIS; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANIMALS; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIVISION; CELLS, CULTURED; DIABETIC NEPHROPATHIES; GLOMERULAR MESANGIUM; GLOMERULONEPHRITIS; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MICE; OSTEONECTIN; PROTEIN KINASE INHIBITORS; PROTEIN KINASES; RECEPTOR, IGF TYPE 1; RNA; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

ANIMALIA; GLOMERULUS;

EID: 0037372760     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.10424     Document Type: Article

References (59)

1. Bach LA. 1992. IGF-I and IGF binding proteins in diabetes- related kidney growth. Growth Regul 2;30-39.
2. Baker J, Liu JP, Robertson EJ, Efstratiadis A. 1993. Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75:73-82.
3. Bassuk JA, Baneyx F, Vernon RB, Funk SE, Sage EH. 1996. Expression of biologically active human SPARC in Escherichia coli. Arch Biochem Biophys 325:8-19.
4. Boney CM, Sekimoto H, Gruppuso PA, Frackelton AR. 2001. Src family tyrosine kinases participate in insulin-like growth factor I mitogenic signaling in 3T3-L1 cells. Cell Growth Differ 12:379-386.
5. Bradshaw AD, Francki A, Motamed K, Howe CC, Sage EH. 1999. Primary mesenchymal cells isolated from SPARC-null mice exhibit altered morphology and rates of proliferation. Mol Biol Cell 10:1569-1579.
6. Bradshaw AD, Bassuk J, Francki A, Sage EH. 2000. Expression and purification of ecombinant human SPARC produced by baculovirus. Mol Cell Biol Res Comm 3:345-351.
7. Brekken RA, Sage EH. 2000. SPARC, a matricellular protein: At the crossroads of cell-matrix communication. Matrix Biol 19:816-827.
8. Chen JC, Shao ZM, Sheikh MS, Hussain A, LeRoith D, Roberts CT, Fontana JA. 1994. Insulin-like growth factor-binding protein enhancement of insulin-like growth factor-I (IGF-I)-mediated DNA synthesis and IGF-I binding in a human breast carcinoma cell line. J Cell Physiol 158:69-78.
9. Dalla Vestra M, Saller A, Bortoloso E, Mauer M, Fioretto P. 2000. Structural involvement in type I and type 2 diabetic nephropathy. Diabetes Metab 26(Suppl 4);8-14.
10. Drop SL, Schuller AG, Lindenbergh-Kortleve DJ, Groffen C, Brinkman A, Zwarthoff EC. 1992. Structural aspects of the IGFBP family. Growth Regul 2:69-79.
11. Ekholm SV, Reed SI. 2000. Regulation of G(1) cyclin-dependent kinases in the mammalian cell cycle. Curr Opin Cell Biol 6:676-684.
12. Ellis MJ, Leav BA, Yang Z, Rasmussen A, Pearce A, Zweibel JA, Lippman ME, Cullen KJ. 1996. Affinity for the insulin-like growth factor-II (IGF-II) receptor inhibits autocrine IGF-II activity in MCF-7 breast cancer cells. Mol Endocrinol 10:286-297.
13. Feld SM, Hirschberg R, Artishevsky A, Nast C, Adler SG. 1995. Insulin-like growth factor 1 induces mesangial proliferation and increases mRNA and secretion of collagen. Kidney Int 48:45-51.
14. Floege J, Topley N, Resch K. 1991. Regulation of mesangial cell proliferation. Am J Kidney Dis 17:673-676.
15. Floege J, Johnson RJ, Alpers CE, Fatemi-Nainie S, Richardson CA, Gordon K, Couser WG. 1993. Visceral glomerular epithelial cells can proliferate in vivo and synthesize platelet-derived growth factor B-chain. Am J Pathol 142:637-650.
16. Francki A, Sage EH. 2001. SPARC and the kidney glomerulus: Matricellular proteins exhibit diverse functions under normal and pathological conditions. Trends Cardiovasc Med 11:32-37.
17. Francki A, Bradshaw AD, Bassuk JA, Howe CC, Couser WG, Sage EH. 1999. SPARC regulates the expression of collagen type I and transforming growth factor-1 in mesangial cells. J Biol Chem 274:32145-32152.
18. Frost RA, Mazella J, Tseng L. 1993. Insulin-like growth factor binding protein-1 inhibits the mitogenic effect of insulin-like growth factors and progestins in human endometrial stromal cells. Biol Reprod 49:104-111.
19. 2+-binding glycoprotein SPARC modulates cell cycle progression in bovine aortic endothelial cells. Proc Natl Acad Sci USA 88:2648-2652.
20. Ge NL, Rudikoff S. 2000. Insulin-like growth factor I is a dual effector of multiple myeloma cell growth. Blood 96:2856-2861.
21. Gilbert RE, McNally PG, Cox A, Dziadek M, Rumble J, Cooper ME, Jerums G. 1995. SPARC gene expression is reduced in early diabetes-related kidney growth. Kidney Int 48:1216-1225.
22. Gooden MD, Vernon RB, Bassuk JA, Sage EH. 1999. Cell cycle-dependent nuclear location of the matricellular protein SPARC: Association with the nuclear matrix. J Cell Biochem 74:152-167.
23. Hammerman MR. 1999. The growth hormone-insulin-like growth factor axis in kidney re-revisited. Nephrol Dial Transplant 14:1853-1860.
24. Hasselaar P, Sage EH. 1992. SPARC antagonizes the effect of basic fibroblast growth factor on the migration of bovine aortic endothelial cells. J Cell Biochem 49:272-283.
25. Hernandez-Sanchez C, Werner H, Roberts CT, Woo EJ, Hum DW, Rosenthal SM, LeRoith D. 1997. Differential regulation of insulin-like growth factor-I (IGF-1) receptor gene expression by IGF-1 and basic fibroblastic growth factor. J Biol Chem 272:4663-4670.
26. Kaelin WG, Jr. 1999. Functions of the retinoblastoma protein. BioEssays 21:950-958.
27. Koshizuka S, Kanazawa K, Kobayashi N, Takazawa I, Waki Y, Shibusawa H, Shumiya S. 1997. The beneficial effects of recombinant human insulin-like growth factor-I (IGF-I) on wound healing in severely wounded senescent mice. Surg Today 27:946-952.
28. Kupprion C, Motamed K, Sage EH. 1998. SPARC (BM-40, osteonectin) inhibits the mitogenic effect of vascular endothelial growth factor on microvascular endothelial cells. J Biol Chem 273:29635-29640.
29. Kurihara S, Hakuno F, Takahashi S. 2000. Insulin-like growth factor-1-dependent signal transduction pathways leading to the induction of cell growth and differentiation of human neuroblastoma cell line SH-SY5Y: The roles of MAPK kinase pathway and PI 3-kinase pathway. Endocr J 47:739-751.
30. Laemmli U. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
31. Lane TF, Iruela-Arispe ML, Sage EH. 1992. Regulation of gene expression by SPARC during angiogenesis in vitro. Changes in fibronectin, thrombospondin-1, and plasminogen activator inhibitor-1. J Biol Chem 267:16736-16745.
32. Lang S, Hartner A, Sterzel RB, Schocklmann HO. 2000. Requirement of cyclin D1 in mesangial cell mitogenesis. J Am Soc Nephrol 11:1398-1408.
33. Lehmann R, Schleicher ED. 2000. Molecular mechanism of diabetic nephropathy. Clin Chim Acta 297:135-144.
34. LeRoith D, McGuinness M, Shemer J, Stannard B, Lanau F, Faria TN, Kato H, Werner H, Adam M, Roberts CT. 1992. Insulin-like growth factors. Biol Signals 4:173-181.
35. Mathews LS, Hammer RE, Behringer RR, D'Ercole AJ, Bell GI, Brinster RL, Palmiter RD. 1988. Growth enhancement of transgenic mice expressing human insulin-like growth factor I. Endocrinology 123:2827-2833.
36. Morgan DO. 1995. Principles of CDK regulation. Nature 374:131-134.
37. Motamed K, Sage EH. 1998. SPARC inhibits endothelial cell adhesion but not proliferation through a tyrosine phosphorylation-dependent pathway. J Cell Biochem 70:543-552.
38. Motamed K, Angello J, Hauschka S, Sage EH. 1999. SPARC inhibits the mitogenic activity of basic fibroblast growth factor on microvascular endothelial cells by blocking the phosphorylation of FGFR-1. FASEB J 13(5):A704 (Abstract).
39. Motamed K, Funk SE, Koyama H, Ross R, Raines ER, Sage EH. 2002. Inhibition of PDGF-stimulated and matrix-mediated proliferation of human vascular smooth muscle cells by SPARC is independent of changes in cell shape or cyclin-dependent kinase inhibitors. J Cell Biochem 84:759-771.
40. 2+-binding EF-hand. J Cell Biochem 57:341-350.
41. Peter M, Herskovitz I. 1994. Joining the complex: Cyclin-dependent kinase inhibitory proteins and the cell cycle. Cell 79:181-184.
42. Pichler RH, Hugo C, Shankland SJ, Reed MJ, Bassuk JA, Andoh TF, Lombardi DM, Schwartz SM, Bennett WM, Alpers CE, Sage EH, Johnson RJ, Couser WG. 1996a. SPARC is expressed in renal interstitial fibrosis and in renal vascular injury. Kidney Int 50:1978-1989.
43. Pichler RH, Bassuk JA, Hugo C, Reed MJ, Eng E, Gordon KL, Pippin J, Alpers CE, Couser WG, Sage EH, Johnson RJ. 1996b. SPARC is expressed by mesangial cells in experimental mesangial proliferative nephritis and inhibits platelet-derived-growth-factor-mediated mesangial cell proliferation in vitro. Am J Pathol 148:1153-1167.
44. Poncelet AC, Schnaper HW. 1998. Regulation of human mesangial cell collagen expression by transforming growth factor-beta1. Am J Physiol 275:458-466.
45. Raines EW, Lane TF, Iruela-Arispe ML, Ross R, Sage EH. 1992. The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors. Proc Natl Acad Sci USA 89:1281-1285.
46. Reed MJ, Puolakkainen P, Lane TF, Dickerson D, Bornstein P, Sage EH. 1993. Differential expression of SPARC and thrombospondin I in wound repair: Immunolocalization and in situ hybridization. J Histochem Cytochem 41:1467-1477.
47. Resnitzky D, Hengst L, Reed SI. 1995. Cyclin A-associated kinase activity is rate limiting for entrance into S phase and is negatively regulated in G1 by p27Kip1. Mol Cell Biol 15:4347-4352.
48. +2-dependent binding to the extracellular matrix. J Cell Biol 109:341-356.
49. Sasaki T, Hohenester E, Göhring W, Timpl R. 1998. Crystal structure and mapping by site-directed mutagenesis of the collagen-binding epitope of an activated form of BM-40/SPARC/osteonectin. EMBO J 17:1625-1634.
50. Schreiber BD, Hughes ML, Groggel GC. 1995. Insulin-like growth factor-1 stimulates production of mesangial cell matrix components. Clin Nephrol 43:368-374.
51. Shankavaram UT, DeWitt DL, Funk SE, Sage EH, Wahl LM. 1997. Regulation of human monocyte matrix metalloproteinases by SPARC. J Cell Physiol 173:327-334.
52. Shankland SJ, Wolf G. 2000. Cell cycle regulatory proteins in renal disease: Role in hypertrophy, proliferation, and apoptosis. Am J Physiol Renal Physiol 278:F515-529.
53. Shankland SJ, Hugo C, Coats SR, Nangaku M, Pichler RH, Gordon KL, Pippin J, Roberts JM, Couser WG, Johnson RJ. 1996. Changes in cell-cycle protein expression during experimental mesangial proliferative glomerulonephritis. Kidney Int 50:1230-1239.
54. Shankland SJ, Pippin J, Flanagan M, Coats SR, Nangaku M, Gordon KL, Roberts JM, Couser WG, Johnson RJ. 1997. Mesangial cell proliferation mediated by PDGF and bFGF is determined by levels of the cyclin kinase inhibitor p27Kip1. Kidney Int 51:1088-1099.
55. Sherr CJ, Roberts JM. 1995. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9:1149-1163.
56. Tremble PM, Lane TF, Sage EH, Werb Z. 1993. SPARC, a secreted protein associated with morphogenesis and tissue remodeling, induces expression of metalloproteinases in fibroblasts through a novel extracellular matrix-dependent pathway. J Cell Biol 121:1433-1444.
57. Wolf G, Ziyadeh FN. 1999. Molecular mechanisms of diabetic renal hypertrophy. Kidney Int 56:393-405.
58. Xu A, Suh PG, Marmy-Conus M, Pearson RB, Seok OY, Cocco L, Gilmour RS. 2001. Phosphorylation of nuclear phospholipase C beta1 by extracellular signal-regulated kinase mediates the mitogenic action of insulin-like growth factor 1. Mol Cell Biol 21:2981-2990.
59. Zapf J. 1995. Physiological role of the insulin-like growth factor binding proteins. Eur J Endocrinol 132:645-654.